missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ ESI 09

Description
ESI 09 is an EPAC inhibitor. Inhibits EPAC-mediated insulin release from pancreatic β cells. Selective for EPAC over PKA. ESI 09 decreases migration and invasion of AsPc-1 and PANC-1 pancreatic cancer cells in vitro.
Specifications
Specifications
| Chemical Name or Material | EPAC Inhibitors |
| CAS | 263707-16-0 |
| Synonym | α-[(2-(3-Chlorophenyl)hydrazinylidene]-5-(1,1-dimethylethyl)-β-oxo-3-isoxazolepropanenitrile |
| Quantity | 10 mg |
| Solubility | Soluble to 100mM in DMSO and to 20mM in ethanol |
| Molecular Formula | C16H15ClN4O2 |
| Formula Weight | 330.77 |
| Physical Form | Solid |
| Product Type | Bioactive Small Molecule |
| Purity | >98% |
Research Use Only. Not For Human or Veterinary Use
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?